# Neurobiological Technologies, Inc. (NTII)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NTII/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2009 | $ 9.12M | $ 8.18M | $ 3.57M | $ 0 | $ 29.13M |
| 2008 | $ 39.90M | $ 4.73M | $ -24.88M | $ 0 | $ 23.55M |
| 2007 | $ 22.35M | $ -24.71M | $ -31.35M | $ 0 | $ 20.29M |
| 2006 | $ 26.76M | $ -21.39M | $ -20.02M | $ 0 | $ -22.09M |
| 2005 | $ 18.68M | $ -52.39M | $ 13.10M | $ 0 | $ -11.40M |
| 2004 | $ 4.69M | $ -26.23M | $ -15.22M | $ 0 | $ 6.00M |
| 2003 | $ 4.22M | $ -2.74M | $ -3.15M | $ 0 | $ 20.72M |
| 2002 | $ 3.00M | $ -4.07M | $ -4.73M | $ 0 | $ 4.25M |
| 2001 | $ 0 | $ -6.46M | $ -7.81M | $ 0 | $ 6.61M |
| 2000 | $ 7.24M | $ 2.41M | $ 2.04M | $ 0 | $ 10.70M |
| 1999 | $ 5 | $ -4.72M | $ -4.85M | $ 0 | $ 7.91M |
| 1997 | $ 151.4K | $ -1.97M | $ -2.27M | $ 0 | $ 1.90M |
| 1996 | $ 616.7K | $ -11.01M | $ -10.60M | $ 0 | $ 3.21M |
| 1995 | $ 766.5K | $ -7.89M | $ -7.92M | $ 0 | $ 10.50M |
| 1994 | $ 1.21M | $ -8.02M | $ -7.57M | $ 0 | $ 8.50M |
| 1993 | $ 302.8K | $ -3.18M | $ -1.67M | $ 0 | $ 13.70M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.02 |
| Current Ratio | 45.33 |

## Other views

- [Metrics](https://sponda.capital/en/NTII.md)
- [Charts](https://sponda.capital/en/NTII/charts.md)
- [Compare](https://sponda.capital/en/NTII/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.